Loading...
•
Mar 31, 2022
ClearPoint Neuro Q1 2022 Earnings Report
ClearPoint Neuro achieved record quarterly revenue in both Functional Neurosurgery Navigation and Biologics and Drug Delivery, with total revenue of $5.0 million, representing a 25% year-over-year growth.
Key Takeaways
ClearPoint Neuro reported a strong first quarter in 2022, achieving record revenue in both Functional Neurosurgery Navigation and Biologics and Drug Delivery, resulting in a total revenue of $5.0 million, a 25% increase year-over-year. The company is increasing its range of expected revenue for 2022 to between $21.0 and $22.0 million.
Achieved record quarterly revenue in both Functional Neurosurgery Navigation and Biologics and Drug Delivery.
Total revenue reached $5.0 million, a 25% increase year-over-year.
Biologics and Drug Delivery team added partners, bringing the total to approximately 45.
Increased the range of expected revenue for 2022 to between $21.0 and $22.0 million.
Revenue by Segment
Forward Guidance
ClearPoint Neuro anticipates revenue between $21.0 and $22.0 million for 2022, which would represent between 30 – 35% growth year-over-year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...